# Methotrexate in Patients with Early Rheumatoid Arthritis

> **NCT05353829** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Region Västerbotten** · enrollment: 212 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT05353829
- **Lead sponsor:** Region Västerbotten
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2025-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05353829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05353829, "Methotrexate in Patients with Early Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05353829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*